Search Results
Sep 03, 2025, 10:30 ET GMP Cell Therapy Consumables Market to Reach USD 114.4 Million by 2035, with CAGR 28.9% Driven by Advanced Cell Therapy and Biopharmaceutical Innovation | Vantage Market Research
https://www.vantagemarketresearch.com/industry-report/single-cell-analysis-market-1295NGS informatics Market: https://www.vantagemarketresearch.com/industry-report/ngs-informatics-market-14394D Printing in Healthcare
More news about: Vantage Market Research
Sep 03, 2025, 09:15 ET Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
-- Illumina Inc. (NASDAQ: ILMN) today announced the launch of Illumina Protein Prep, an assay introducing superior performance for next-generation sequencing (NGS) based proteomics discovery at scale.
More news about: Illumina, Inc.
Sep 03, 2025, 09:15 ET Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
-- Illumina Inc. (NASDAQ: ILMN) today announced the launch of Illumina Protein Prep, an assay introducing superior performance for next-generation sequencing (NGS) based proteomics discovery at scale.
More news about: Illumina, Inc.
Sep 02, 2025, 10:00 ET GeneseeqPrime® Gains FDA 510(k) Clearance
GENESEEQPRIME® NGS Tumor Profiling Assay, an in vitro diagnostic (IVD) test kit that uses next-generation sequencing (NGS) of DNA from FFPE tumor tissue to detect tumor gene alterations across a comprehensive multi
More news about: Geneseeq Technology Inc.
Sep 02, 2025, 02:20 ET Global Cancer Diagnostics Market to Hit USD 215 Billion by 2035, Growing at 6.35% CAGR | Vantage Market Research
41.6% market share, with the U.S. leading global adoption of advanced molecular diagnostics, companion diagnostics, and next-generation sequencing (NGS). The region benefits from strong R&D investments, a well-established regulatory framework, and widespread reimbursement coverage, which ensure faster
More news about: Vantage Market Research
Aug 28, 2025, 10:45 ET Life Science Tools Market to Grow at a CAGR of 10.81% from 2025 to 2032 | SkyQuest Technology Consulting
The growing focus on personalized therapies and genetic testing is driving demand for advanced life science tools such as NGS platforms, PCR systems, and genomic analysis software. WESTFORD, Mass.,
More news about: SkyQuest Technology
Aug 28, 2025, 10:31 ET Cancer Diagnostics Market to Grow at a CAGR of 9.4% from 2025 to 2032 | SkyQuest Technology Consulting
USD 48.49 Billion by the end of 2032. Innovations in diagnostic technologies, including liquid biopsies, next-generation sequencing (NGS), and AI-enabled imaging, are transforming cancer diagnostics. These advancements enhance accuracy, reduce diagnostic time, and enable non-invasive procedures.
More news about: SkyQuest Technology
Aug 26, 2025, 07:30 ET PackGene to Offer Barcoded High-Throughput AAV Capsid Screening Kits Through Strategic License Agreement with Children's Medical Research Institute
Head of the Translational Vectorology Research Unit at CMRI. "CMRI has pioneered the work of establishing barcoded AAV capsid kits, which allow for NGS-based parallel evaluation of large numbers of AAVs for their performance at both DNA (proxy for cell entry) and RNA (proxy for transgene expression)
More news about: Packgene
Aug 25, 2025, 10:01 ET Single Cell Sequencing Market worth $3.46 billion by 2030 with 12.2% CAGR | MarketsandMarkets™
October 2024, BD launched its BD OMICS-One XT WTA Assay, a high-throughput reagent kit designed with the Hamilton Microlab NGS STAR liquid-handling platform. This kit helps genomics labs automate and standardize their single-cell workflows, reducing manual steps and improving
More news about: MarketsandMarkets
Aug 22, 2025, 10:01 ET Epigenetics Market is expected to generate a revenue of USD 3.70 Billion by 2031, Globally, at 13.94% CAGR: Verified Market Research®
Global De Novo Sequencing Market Size By Technology (Next-Generation Sequencing (NGS), Sanger Sequencing, Third-Generation Sequencing (TGS)), By Application (Whole Genome Sequencing, Targeted Sequencing, Transcriptome Sequencing, Metagenomics,
More news about: Verified Market Research
Aug 20, 2025, 17:46 ET Global Minimal Residual Disease Testing Market Gearing Up for Outstanding Expansion at a CAGR of ~11% by 2032 | DelveInsight
them early is critical for managing and monitoring the disease. MRD testing uses highly sensitive techniques such as PCR, next-generation sequencing (NGS), or flow cytometry to quantify these remaining cancer cells at very low levels. It has become particularly important in hematologic malignancies like
More news about: DelveInsight Business Research, LLP
Aug 20, 2025, 10:30 ET In-Vitro Diagnostics Market is Poised to Reach USD 153.3 Billion by 2032 | SkyQuest Technology Consulting
February 2025, F. Hoffmann-La Roche Ltd (Switzerland) introduced a new class of next-generation sequencing (NGS) technology, powered by Sequencing by Expansion (SBX). This innovation is designed to deliver faster, more precise, and highly scalable sequencing capabilities.
More news about: SkyQuest Technology
Aug 19, 2025, 11:15 ET Parter and Gaia Dynamics Announce Strategic Partnership to Automate Tariffs and Compliance for Electronics Supply Chains
Gaia Dynamics Gaia Dynamics is an AI-driven trade technology platform founded in 2025 in partnership with Andrew Ng's AI Fund. Headquartered in Palo Alto, California, the company leverages cutting-edge artificial intelligence to simplify
More news about: Gaia Dynamics
Aug 19, 2025, 08:00 ET Ultima Genomics and Gene by Gene Partner to Expand Global Access to High-Quality, Low-Cost Sequencing on the UG 100™ Platform
Ultima Genomics, Inc., developer of the UG 100™ next-generation sequencing (NGS) platform, and
More news about: Ultima Genomics
Aug 15, 2025, 11:00 ET Epigenetics Market worth US$4.29 billion in 2030 with 13.9% CAGR | MarketsandMarkets™
in healthcare infrastructure in emerging economies. Moreover, there is a heightened emphasis on advancing capabilities in Next-Generation Sequencing (NGS), which is further propelling market development in the region. Request Sample Pages :
More news about: MarketsandMarkets
Aug 15, 2025, 09:02 ET Global DNA Forensics Market Accelerates with Growing Demand for High-Tech Investigative Solutions | 'BCC Research LLC'
review of the global DNA forensics market, segmented by product types (kits, equipment, software), sources (blood, bones, hair), techniques (PCR, STR, NGS, etc.), applications (criminal testing, paternity and familial testing), and end users (forensic labs, research institutes). It also analyzes market
More news about: BCC Research LLC
Aug 15, 2025, 08:30 ET Caris Life Sciences Demonstrates Scientific Rigor with Clinical Validation of FDA-Approved MI Cancer Seek®
can reduce inefficiencies and potentially help more patients access personalized therapies." MI Cancer Seek is a next-generation sequencing (NGS) based in vitro diagnostic (IVD) device using total nucleic acid (TNA) isolated from formalin-fixed paraffin-embedded (FFPE) tumor tissue specimens
More news about: Caris Life Sciences
Aug 14, 2025, 13:40 ET Ultima Genomics' ppmSeq™ Delivers Unmatched Combination of Sensitivity and Efficiency for Whole-Genome MRD Detection
These challenges limit the ability of traditional NGS technologies to detect and identify rare variants, a feature which is important in emerging applications like MRD and somatic mosaicism. To increase the ability to detect rare variants, current NGS approaches often rely on error-correction techniques,
More news about: Ultima Genomics
Aug 14, 2025, 10:00 ET Gaia Dynamics Welcomes Global Director of Trade Bojan Strbanovic to Advisory Board
Gaia Dynamics Gaia Dynamics is an AI-driven trade technology platform founded in 2025 in partnership with Andrew Ng's AI Fund. Headquartered in Palo Alto, California, the company leverages cutting-edge artificial intelligence to simplify
More news about: Gaia Dynamics
Aug 13, 2025, 10:32 ET Whole Genome Sequencing Market to Reach New Heights by 2030
explores market drivers, restraints, and opportunities, along with competitive dynamics and product offerings. The market is segmented by technology (NGS, TGS, pyrosequencing, and Sanger sequencing), product and service types, end users, applications, and disease categories. It also includes company profiles
More news about: BCC Research LLC
Aug 12, 2025, 08:30 ET Genedata Next-Gen Software to Power GMP-Compliant NGS in Biopharma Manufacturing
support expanded Multi-Attribute Method (MAM) applications, this software release also includes a broad catalog of NGS workflow activities, enabling companies to unlock the full potential of NGS assays in house. The new version of Genedata Selector connects with data management systems such as LIMS, ELNs,
More news about: Genedata
Aug 12, 2025, 03:52 ET 慎選用藥提升標靶治療續航力，為晚期肺癌病人帶來生命曙光
談到精準選藥，蔡醫師不忘提到基因檢測、特別是次世代定序（NGS）在當中扮演的角色。他強調，ALK 基因突變可進一步細分為不同亞型，然後不同亞型對於藥物的反應也會有差別。此外，病人如果除 ALK 以外同時具有其他突變，不論是抑癌基因還是另一些驅動基因，同樣有可能縮短病人的 PFS，使其預後變得較差。有鑑於此，若能透過完整的 NGS 檢測掌握相關資訊，將有望為醫師在藥物選擇上提供有力依據。 晚期肺癌慢性病化時代來臨，醫病溝通釐清誤解至關重要 不少罹患 ALK 陽性 NSCLC 的病人正值青壯年，甚至是家庭經濟支柱，面對癌魔突然來襲，他們亟欲尋找高療效且能盡量延長壽命的新藥也是無可厚非。另一方面，隨著診斷技術不斷進步，精準療法與標靶藥物應運而生，病人即使在確診時已屆晚期，只要藥物運用得宜，存活期也的確有望大幅延長。事實上，近年來肺癌（包括
More news about: 基因線上
Aug 11, 2025, 06:30 ET Space-ng Unveils Computer Vision Hardware/Software Development Kit at Small Sat
SALT LAKE CITY, Aug. 11, 2025 /PRNewswire/ -- Space-ng's
More news about: Space-ng Inc.
Aug 06, 2025, 15:16 ET Nifty Gateway Studio and Other World Present "The Garden of Other Worldly Delights" - AI Judgment Meets Classic Sin in Monumental Reimagining of Bosch's Triptych
Nifty Gateway Studio ("NGS") is a full-service digital production studio specializing in creating immersive, onchain social entertainment and creative experiences. NGS partners with leading creators and brands to develop innovative projects that
More news about: Nifty Gateway Studio
Aug 06, 2025, 10:45 ET Biomarkers Market to Grow at a CAGR of 12.3% from 2025 to 2032 | SkyQuest Technology Consulting
is foundational for personalized medicine and understanding disease at the molecular level.By technology, Next-Generation Sequencing (NGS) dominates owing to its ability to perform rapid, large-scale genetic analysis, enabling more precise and comprehensive biomarker discovery.By
More news about: SkyQuest Technology